Literature DB >> 24631531

MicroRNA-363-mediated downregulation of S1PR1 suppresses the proliferation of hepatocellular carcinoma cells.

Peng Zhou1, Gang Huang1, Yuanyin Zhao1, Dan Zhong1, Zhizhen Xu1, Yijun Zeng1, Yan Zhang1, Song Li2, Fengtian He3.   

Abstract

S1PR1 plays a crucial role in promoting proliferation of hepatocellular carcinoma (HCC). Over expression of S1PR1 is observed in HCC cell lines. The mechanisms underlying the aberrant expression of S1PR1 are not known well. MircroRNAs are important regulators of gene expression and disproportionate microRNAs can result in dysregulation of oncogenes in cancer cells. In this study, we found that miR-363, a potential tumor suppressor microRNA, downregulated the expression of S1PR1 and inhibited the proliferation of HCC cells. Bioinformatic analysis predicted a putative binding site of miR-363 within the 3'-UTR of S1PR1 mRNA. Luciferase reporter assay showed that miR-363 directly targeted the 3'-UTR of S1PR1 mRNA. Transfection of miR-363 mimics suppressed S1PR1 expression in HCC cells, followed by the repression of the activation of ERK and STAT3. Moreover, we found that the expression of downstream genes of ERK and STAT3, including PDGF-A, PDGF-B, MCL-1 and Bcl-xL, was suppressed after miR-363 transfection. Taken together, the present study demonstrated that miR-363 was a negative regulator of S1PR1 expression in HCC cells and inhibited cell proliferation, suggesting that the miR-363/S1PR1 pathway might be a novel target for the treatment of HCC.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hepatocellular carcinoma; MicroRNA-363; Proliferation; Sphingosine-1-phosphate receptor-1

Mesh:

Substances:

Year:  2014        PMID: 24631531     DOI: 10.1016/j.cellsig.2014.02.020

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  33 in total

1.  microRNA-363 plays a tumor suppressive role in osteosarcoma by directly targeting MAP2K4.

Authors:  Xueqin Li; Xinsheng Liu; Jun Fang; Huazhuang Li; Jingchun Chen
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 2.  Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer.

Authors:  Nijiro Nohata; Yusuke Goto; J Silvio Gutkind
Journal:  J Hum Genet       Date:  2016-10-13       Impact factor: 3.172

3.  MicroRNA expression profiles in pediatric dysembryoplastic neuroepithelial tumors.

Authors:  M Braoudaki; G I Lambrou; S A Papadodima; K Stefanaki; N Prodromou; E Kanavakis
Journal:  Med Oncol       Date:  2015-12-23       Impact factor: 3.064

4.  Role of Sphingosine Kinase 1 and Sphingosine-1-Phosphate Axis in Hepatocellular Carcinoma.

Authors:  Michael Maceyka; Timothy Rohrbach; Sheldon Milstien; Sarah Spiegel
Journal:  Handb Exp Pharmacol       Date:  2020

5.  LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells.

Authors:  H Xiong; Z Ni; J He; S Jiang; X Li; J He; W Gong; L Zheng; S Chen; B Li; N Zhang; X Lyu; G Huang; B Chen; Y Zhang; F He
Journal:  Oncogene       Date:  2017-02-06       Impact factor: 9.867

6.  Downregulation of rho-associated protein kinase 1 by miR-124 in colorectal cancer.

Authors:  Zuo-Wu Xi; Shi-Yong Xin; Li-Qing Zhou; Hai-Xin Yuan; Qian Wang; Kai-Xuan Chen
Journal:  World J Gastroenterol       Date:  2015-05-14       Impact factor: 5.742

7.  Targeting the MIR34C-5p-ATG4B-autophagy axis enhances the sensitivity of cervical cancer cells to pirarubicin.

Authors:  Yaran Wu; Zhenhong Ni; Xiaojing Yan; Xufang Dai; Changjiang Hu; Yingru Zheng; Fengtian He; Jiqin Lian
Journal:  Autophagy       Date:  2016-04-20       Impact factor: 16.016

8.  MicroRNA-363-3p Inhibits the Expression of Renal Fibrosis Markers in TGF-β1-Treated HK-2 Cells by Targeting TGF-β2.

Authors:  Xiangnan Dong; Yang Li; Rui Cao; Honglan Xu
Journal:  Biochem Genet       Date:  2021-02-25       Impact factor: 1.890

9.  MicroRNA-363-3p inhibits papillary thyroid carcinoma progression by targeting PIK3CA.

Authors:  Jia Liu; Qun Li; Rui Li; Peiyou Ren; Su Dong
Journal:  Am J Cancer Res       Date:  2017-01-01       Impact factor: 5.942

Review 10.  miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents.

Authors:  Volker Baumann; Johannes Winkler
Journal:  Future Med Chem       Date:  2014       Impact factor: 3.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.